These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932 [TBL] [Abstract][Full Text] [Related]
7. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602 [TBL] [Abstract][Full Text] [Related]
8. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
10. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi. Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412 [TBL] [Abstract][Full Text] [Related]
11. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
12. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
14. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance. Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412 [TBL] [Abstract][Full Text] [Related]
15. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice. LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132 [TBL] [Abstract][Full Text] [Related]
16. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508 [TBL] [Abstract][Full Text] [Related]
17. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704 [TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121 [TBL] [Abstract][Full Text] [Related]
19. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]